FDA to Consider Genetically Modified Salmon for U.S. Consumption
The case for allowing genetically-modified food to enter the U.S. marketplace has taken a strong step forward. FDA recently (Rockville, MD) announced its intent to hold a meeting in mid-September with AquaBounty Technologies (Waltham, MA), a biotech company wishing to bring its genetically-modified salmon to market. The company says its AquAdvantage salmon grow twice as fast as conventionally grown salmon; but they do not grow bigger.
The case for allowing genetically-modified food to enter the U.S. marketplace has taken a strong step forward. FDA recently (Rockville, MD) announced its intent to hold a meeting in mid-September with AquaBounty Technologies (Waltham, MA), a biotech company wishing to bring its genetically-modified salmon to market.
The company says its AquAdvantage salmon grow twice as fast as conventionally grown salmon; but they do not grow bigger.
FDA has scheduled a two-day session for September 19-20, with the company and FDA...s Veterinary Medicine Advisory Committee, to overview data on safety and effectiveness of the salmon, and to allow for public opinion (only to individuals registered before the meeting).
According to the New York Times, FDA is expected to make a final decision on the approval of AquAdvantage salmon in the weeks following the meetings. If an approval is granted, it may take two to three years for the salmon to reach American markets, the New York Times added.
Nutritional Outlook will continue reporting on genetically modified organisms (GMOs) here at www.nutritionaloutlook.com.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
